S122 A role for the bone morphogenetic protein type 2 receptor (bmpr2) in differentiation of the common myeloid progenitor lineage in mice and humans. (15th November 2017)

• Record Type: Journal Article
• Authors: Crosby, A; Hadinnapola, C; Groves, E; Moore, S; Dunmore, BD; Southwood, M; Horan, IP; Bleda, M; Haimel, M; Gräf, S; Toshner, MR; Morrell, NW
• Is Part Of: Thorax. Volume 72(2017)Supplement 3
• Page Start: A73
• Page End: A74
• Publication Date: 2017-11-15
• Subjects: Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2017-210983.128
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Rationale: There is increasing evidence of a link between abnormalities in the myeloid cell lineage and pulmonary arterial hypertension (PAH). Heterozygous mutations in the gene encoding the bone morphogenetic protein type 2 receptor ( BMPR2 ) are the most common genetic cause of PAH. We sought to characterise the impact of the genetic loss/reduction of BMPR2 function in the myeloid lineage in mice and humans, and whether this altered susceptibility to PAH. Methods: Mx1-cre mice were crossed with bmpr2 flox/flox mice. At approximately 8 weeks of age cre-recombinase was induced with polyinosinic-polycytidylic acid (Poly I:C). Control mice ( bmpr2 flox/flox mice with no cre) were also induced with Poly I:C. At approximately 16 weeks post-induction mice underwent right-heart catheterisation, exsanguination and tissue was removed for analysis. The spleens were weighed and histology was performed on the femurs. Mouse data are presented as mean ±SEM. In a large cohort of PAH patients with (n=160) and without (n=831) BMPR2 mutations blood count indices were analysed. Data presented as median [IQR]. Results: 16 weeks after induction of cre-recombinase in Mx1-cre/ bmpr2 flox/flox mice we observed significant increases (p<0.05) in red blood cells (x10 6 /mm 3 ) (12.7±0.9 compared with 12.1±0.2), haematocrit (%) (64.8±0.7 compared with 62.6±1) and haemoglobin (g/dl) (16±0.9 compared with 15.4±0.2) compared with bmpr2 flox/flox mice alone. A significant increase in circulating monocytes (x10 3 /mm 3 ) was also observed (p<0.05) (0.4±0.05 compared with 0.3±0.05). In addition, we identified a significant increase (p<0.05) in megakaryocytes in the femurs (80±10 compared with 17±5) and a significant increase (p<0.01) in the ratio of spleen weight/body weight (0.003±0.0001 compared with 0.002±0.0001) in Mx1-cre/ bmpr2 flox/flox mice. During right heart catheterisation right ventricular systolic pressures were similar in both groups. In PAH patients significant differences (p<0.05) were seen in haemoglobin ( BMPR2 mutation: 162 g/L [151.75–173]) vs. no mutation: 150 g/L [135 – 163]), haematocrit (0.48 [0.45–0.52] vs. 0.44 [0.41–0.48]) and white blood cells (8.8 [7.3–10.4] vs. 8.11 [6.77–9.61]). Conclusions: we have identified a role for bmpr2 in the differentiation of the mouse myeloid lineage, which was also confirmed in PAH patients with BMPR2 mutations. BMPR2 appears particularly important in the differentiation of megakaryocyte-erythrocyte lineage.